BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 30599763)

  • 1. Incidence and Management of Clozapine-Induced Myocarditis in a Large Tertiary Hospital.
    Higgins JM; San C; Lagnado G; Chua D; Mihic T
    Can J Psychiatry; 2019 Aug; 64(8):561-567. PubMed ID: 30599763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy.
    Segev A; Iqbal E; McDonagh TA; Casetta C; Oloyede E; Piper S; Plymen CM; MacCabe JH
    Br J Psychiatry; 2021 Dec; 219(6):644-651. PubMed ID: 35048875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocarditis and cardiomyopathy associated with clozapine.
    Kilian JG; Kerr K; Lawrence C; Celermajer DS
    Lancet; 1999 Nov; 354(9193):1841-5. PubMed ID: 10584719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine-induced myocarditis and patient outcomes after drug rechallenge following myocarditis: A systematic case review.
    Richardson N; Greenway SC; Bousman CA
    Psychiatry Res; 2021 Nov; 305():114247. PubMed ID: 34715441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for Clozapine Rechallenge in a Case of Clozapine-Induced Myocarditis.
    Shivakumar G; Thomas N; Sollychin M; Takács A; Kolamunna S; Melgar P; Connally F; Neil C; Bousman C; Jayaram M; Pantelis C
    Can J Psychiatry; 2020 Jul; 65(7):448-453. PubMed ID: 31818135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine and incidence of myocarditis and sudden death - Long term Australian experience.
    Khan AA; Ashraf A; Baker D; Al-Omary MS; Savage L; Ekmejian A; Singh RSH; Brienesse S; Majeed T; Gordon T; Drinkwater V; Collins NJ
    Int J Cardiol; 2017 Jul; 238():136-139. PubMed ID: 28343762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the higher incidence of clozapine induced myocarditis in Australia due to awareness and monitoring?
    Dawson JL; Clark SR; Sluggett JK; Procter NG; Bell JS
    Schizophr Res; 2018 Nov; 201():426-427. PubMed ID: 29907491
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls.
    Ronaldson KJ; Taylor AJ; Fitzgerald PB; Topliss DJ; Elsik M; McNeil JJ
    J Clin Psychiatry; 2010 Aug; 71(8):976-81. PubMed ID: 20361910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service.
    Reinders J; Parsonage W; Lange D; Potter JM; Plever S
    Aust N Z J Psychiatry; 2004; 38(11-12):915-22. PubMed ID: 15555025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and investigation of potential risk-factors for clozapine-associated myocarditis and cardiomyopathy in a New Zealand cohort.
    Bellissima BL; Vara A; Helsby N; Garavan F; Tingle MD
    Psychiatry Res; 2021 May; 299():113873. PubMed ID: 33799127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Rechallenge with Clozapine Following Pronounced Myocarditis in a Treatment-Resistant Schizophrenia Patient.
    Ittasakul P; Archer A; Kezman J; Atsariyasing W; Goldman MB
    Clin Schizophr Relat Psychoses; 2016; 10(2):120-2. PubMed ID: 27440213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine-Induced Myocarditis: The Heartfelt Silent Assassin.
    Deardorff OG; Conklin TM; Hopkins TM; Hall LR; Trout MG; Cafer J
    Prim Care Companion CNS Disord; 2018 Oct; 20(5):. PubMed ID: 30326189
    [No Abstract]   [Full Text] [Related]  

  • 13. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls.
    Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; McNeil JJ
    Aust N Z J Psychiatry; 2011 Jun; 45(6):458-65. PubMed ID: 21524186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine-induced myocarditis, a widely overlooked adverse reaction.
    Ronaldson KJ; Fitzgerald PB; McNeil JJ
    Acta Psychiatr Scand; 2015 Oct; 132(4):231-40. PubMed ID: 25865238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine-induced myocarditis: A rare adverse drug reaction not to ignore.
    Masmoudi R; Baati I; Ksouda K; Abida I; Sellami R; Affes H; Trigui D; Masmoudi J; Feki I
    Therapie; 2019 Jun; 74(3):441-444. PubMed ID: 30197229
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful rechallenge after clozapine-associated myocarditis.
    Holden J; Begum M
    BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35550318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient Clozapine-induced Myocarditis Without Discontinuation of Medication: A Series of 2 Patients.
    Klein N; Barnett L; Guirgis H; Stearns WH
    J Psychiatr Pract; 2022 Mar; 28(2):170-175. PubMed ID: 35238829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia.
    Youssef DL; Narayanan P; Gill N
    Australas Psychiatry; 2016 Apr; 24(2):176-80. PubMed ID: 26400457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine-Associated Myocarditis: A Protocol for Monitoring Upon Clozapine Initiation and Recommendations for How to Conduct a Clozapine Rechallenge.
    Griffin JM; Woznica E; Gilotra NA; Nucifora FC
    J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):180-185. PubMed ID: 33587399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine and myocarditis: a case series from the New Zealand Intensive Medicines Monitoring Programme.
    Hill GR; Harrison-Woolrych M
    N Z Med J; 2008 Oct; 121(1283):68-75. PubMed ID: 18841187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.